News
Exciting Milestone Achieved: Site Registration in South Korea
Monday, March 10, 2025
UI Pharmaceuticals successfully completes site registration in South Korea for manufacturing a gel formulation used as antineoplastic drug.
UI Pharmaceuticals Reaches Milestone
Thursday, January 30, 2025
UI Pharmaceuticals collaborates with MimiVax to manufacture new Glioblastoma vaccine.
UI Pharmaceuticals Advancing Production
Monday, August 5, 2024
The University of Iowa College of Pharmacy is pleased to announce that UI Pharmaceuticals (UIP) has validated its new sterile processing facility.
UI Pharmaceuticals Partners with Protostudios
Thursday, August 25, 2022
The engineering and facilities team at UI Pharmaceuticals, the College of Pharmacy’s FDA-registered drug development and manufacturing organization, has been working on innovative ideas and solutions to overcome process and mechanical challenges with the College’s unique pharmaceutical fill-line equipment.
UI Pharmaceutical Client, Actuate Therapeutics Receives Fast Track FDA Designation for 9-ING-41
Tuesday, August 17, 2021
UI Pharmaceuticals Client, G1 Therapeutics Receives FDA Approval for COSELA™ (Trilaciclib)
Saturday, April 17, 2021